195 related articles for article (PubMed ID: 17635755)
1. Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome.
Davenport A; Stearns MP
Nephrology (Carlton); 2007 Aug; 12(4):386-90. PubMed ID: 17635755
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica.
França TC; Griz L; Pinho J; Diniz ET; Andrade LD; Lucena CS; Beserra SR; Asano NM; Duarte AP; Bandeira F
Rev Bras Reumatol; 2011; 51(2):131-7. PubMed ID: 21584419
[TBL] [Abstract][Full Text] [Related]
3. Possible prevention of hungry bone syndrome following parathyroidectomy by preoperative use of pamidronate.
Gurevich Y; Poretsky L
Otolaryngol Head Neck Surg; 2008 Mar; 138(3):403-4. PubMed ID: 18312894
[No Abstract] [Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
[TBL] [Abstract][Full Text] [Related]
6. [Calcium needs in hemodialyzed-parathyroidectomized patients].
Zahiri K; Hachim K; Fatihi el M; Benghanem MG; Ramdani B; Zaïd D
Ann Med Interne (Paris); 2002 Nov; 153(7):433-9. PubMed ID: 12598828
[TBL] [Abstract][Full Text] [Related]
7. Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. The results of the first 12 months of pamidronate therapy.
Kraj M; Pogłód R; Pawlikowski J; Maj S; Nasiłowska B
Acta Pol Pharm; 2000 Nov; 57 Suppl():113-6. PubMed ID: 11293237
[TBL] [Abstract][Full Text] [Related]
8. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
[TBL] [Abstract][Full Text] [Related]
9. [Anesthesia and postoperative recovery for parathyroid gland surgery].
Roland E
Ann Chir; 1999; 53(2):150-61. PubMed ID: 10089669
[TBL] [Abstract][Full Text] [Related]
10. [Parathyroidectomy in end-stage renal disease: perioperative management of calcium-phosphorus balance].
Vallée M; Lalumière G; Déziel C; Quérin S; Madore F
Ann Biol Clin (Paris); 2007; 65(1):71-6. PubMed ID: 17264042
[TBL] [Abstract][Full Text] [Related]
11. Hungry bone syndrome.
Jain N; Reilly RF
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):250-255. PubMed ID: 28375869
[TBL] [Abstract][Full Text] [Related]
12. Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy.
Kim SH; Lim SK; Hahn JS
Am J Med; 2004 Apr; 116(8):524-8. PubMed ID: 15063813
[TBL] [Abstract][Full Text] [Related]
13. The impact of age, vitamin D(3) level, and incidental parathyroidectomy on postoperative hypocalcemia after total or near total thyroidectomy.
Erbil Y; Barbaros U; Temel B; Turkoglu U; Işsever H; Bozbora A; Ozarmağan S; Tezelman S
Am J Surg; 2009 Apr; 197(4):439-46. PubMed ID: 19324110
[TBL] [Abstract][Full Text] [Related]
14. Management of calcium refilling post-parathyroidectomy in end-stage renal disease.
Cozzolino M; Gallieni M; Corsi C; Bastagli A; Brancaccio D
J Nephrol; 2004; 17(1):3-8. PubMed ID: 15151253
[TBL] [Abstract][Full Text] [Related]
15. Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy.
Vallo A; Rodriguez-Leyva F; Rodríguez Soriano J
Acta Paediatr; 2006 Mar; 95(3):332-9. PubMed ID: 16497645
[TBL] [Abstract][Full Text] [Related]
16. Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: a series of five case reports.
Nogueira EL; Costa AC; Santana A; Guerra JO; Silva S; Mil-Homens C; Costa AG
Transplantation; 2011 Aug; 92(3):316-20. PubMed ID: 21694663
[TBL] [Abstract][Full Text] [Related]
17. Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol.
Wong J; Fu WH; Lim ELA; Ng CFJ; Choong HL
Int Urol Nephrol; 2020 Mar; 52(3):557-564. PubMed ID: 32016909
[TBL] [Abstract][Full Text] [Related]
18. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
Brown JJ; Zacharin MR
J Paediatr Child Health; 2005 Nov; 41(11):580-2. PubMed ID: 16398842
[TBL] [Abstract][Full Text] [Related]
19. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome.
Solau-Gervais E; Soubrier M; Gerot I; Grange L; Puechal X; Sordet C; Sibilia J; Duquesnoy B
Rheumatology (Oxford); 2006 Mar; 45(3):339-42. PubMed ID: 16249241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
